Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Adaptimmune Therapeutics PLC (ADAP) - free report >>
CollPlant Biotechnologies Ltd. Sponsored ADR (CLGN) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Adaptimmune Therapeutics PLC (ADAP) - free report >>
CollPlant Biotechnologies Ltd. Sponsored ADR (CLGN) - free report >>
Image: Bigstock
New Strong Sell Stocks for April 22nd
Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:
Bed Bath & Beyond is a leading operator of specialty retail stores in the United States and Canada. The Zacks Consensus Estimate for its current year earnings has been revised 391.9% downward over the last 60 days.
CollPlant Biotechnologies (CLGN - Free Report) is a regenerative medicine company. The Zacks Consensus Estimate for its current year earnings has been revised 121.5% downward over the last 60 days.
Adaptimmune Therapeutics is a biopharmaceutical company that focuses on cancer immunotherapy products based on T-cell receptor platform. The Zacks Consensus Estimate for its current year earnings has been revised almost 18.7% downward over the last 60 days.
View the entire Zacks Rank #5 List.